Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

912
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
912
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

841
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
841
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

926
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
926
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

989
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
989
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

1.6K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guselkumab - In Psoriasis and Beyond.

Dermatology practical & conceptual·2024
Same author

Comparison of the clinical efficacy of topical tretinoin 0.05% cream and tacrolimus 0.1% ointment plus iontophoresis in the management of palmoplantar psoriasis.

Clinical and experimental dermatology·2024
Same author

Saxophone penis: A sequel to penoscrotal hidradenitis suppurativa.

Indian journal of sexually transmitted diseases and AIDS·2023
Same author

Giant Solitary Trichoepithelioma: A Diagnosis of Exclusion.

International journal of trichology·2023
Same author

Penile lichen planus mimicking psoriasis clinically and delineating two different patterns on histopathology.

Indian journal of sexually transmitted diseases and AIDS·2022
Same author

A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.

Dermatologic therapy·2022
Same journal

Retraction: The effects of tramadol on hepatic ischemia/reperfusion injury in rats.

Indian journal of pharmacology·2026
Same journal

Comment on Bellapu, Dhanush, et al., sodium glucose co-transporter 2 inhibitors safety depending on their adverse drug reactions and glucose monitoring parameters in type 2 diabetes mellitus.

Indian journal of pharmacology·2026
Same journal

Torsemide and warfarin: A cautionary case of altered international normalized ratio and bleeding risk.

Indian journal of pharmacology·2026
Same journal

Nivolumab-induced folliculitis: A case of immune-related cutaneous adverse reaction.

Indian journal of pharmacology·2026
Same journal

Tapentadol-induced urticarial rash in a patient with acute pancreatitis.

Indian journal of pharmacology·2026
Same journal

Suzetrigine: A promising analgesic targeting voltage-gated sodium channel.

Indian journal of pharmacology·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K

Metformin - For the dermatologist.

Aditya Kumar Bubna1

  • 1Assistant Professor, Department of Dermatology, Sri Ramachandra University, Porur, Chennai, Tamil Nadu, India.

Indian Journal of Pharmacology
|March 22, 2016
PubMed
Summary
This summary is machine-generated.

Metformin, an antidiabetic medication, shows significant benefits in various skin conditions like hormonal acne and psoriasis. Its anti-inflammatory and antiandrogenic effects make it a versatile treatment option for dermatologists.

Keywords:
Hyperandrogenismhyperinsulinemiahyperpigmentary disordersmetforminskin cancer

More Related Videos

Fixation and Operational Method for Abdominal Massage in T2DM Mice
05:57

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

853
Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
08:45

Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts

Published on: March 18, 2016

7.3K

Related Experiment Videos

Last Updated: Mar 23, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Fixation and Operational Method for Abdominal Massage in T2DM Mice
05:57

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

853
Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
08:45

Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts

Published on: March 18, 2016

7.3K

Area of Science:

  • Dermatology
  • Endocrinology
  • Pharmacology

Background:

  • Metformin is primarily an antidiabetic drug.
  • It influences hyperinsulinemia and possesses antiandrogenic properties.

Purpose of the Study:

  • To explore the dermatological applications of metformin beyond its antidiabetic role.
  • To highlight metformin's efficacy in treating various cutaneous disorders.

Main Methods:

  • Review of existing literature on metformin's use in dermatology.
  • Analysis of clinical outcomes in patients with hormonal acne, hidradenitis suppurativa, acanthosis nigricans, hirsutism, psoriasis, cutaneous malignancies, and hyperpigmentary disorders.

Main Results:

  • Metformin improves hyperinsulinemia, benefiting hormonal acne, hidradenitis suppurativa, and acanthosis nigricans.
  • Antiandrogenic effects aid in managing hirsutism associated with PCOS.
  • Systemic and topical metformin show promise in psoriasis, malignancies, and hyperpigmentation.

Conclusions:

  • Metformin demonstrates a broad spectrum of efficacy in dermatological conditions.
  • Its utility extends from hormonal and inflammatory skin diseases to pigmentary disorders and malignancies.
  • Metformin is a valuable therapeutic agent for dermatologists.